Proteogenomic convergence for understanding cancer pathways and networks

Clinical Proteomics

Volumn 11, Issue 1, 2014, Pages

  Boja, Emily S ^a   Rodriguez, Henry ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Mathematical and computational modeling; Omics integration; Post Translational modification; Protein identification and quantitation; Protein networks; Proteogenomics; Signaling pathways; Systems biology; Targeted proteomics

Indexed keywords

PROTEOME;

BIOINFORMATICS; CANCER GENETICS; CANCER GROWTH; CANCER RESEARCH; CARCINOGENESIS; CELL ACTIVITY; CYTOARCHITECTURE; GENE EXPRESSION PROFILING; GENE MAPPING; GENE SEQUENCE; GENETIC ANALYSIS; GENOMICS; GENOTYPE; HUMAN; INTRACELLULAR SIGNALING; MOLECULAR GENETICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; PROTEOGENOMIC CONVERGENCE; PROTEOMICS; QUANTITATIVE ANALYSIS; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS;

EID: 84903767693     PISSN: 15426416     EISSN: 15590275     Source Type: Journal    
DOI: 10.1186/1559-0275-11-22     Document Type: Review

References (148)

1. Cancer Genome Atlas Research Network: Integrated genomic analyses of ovarian carcinoma. Nature 2011, 474(7353):609-615.
2. Cancer Genome Atlas Research Network: Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008, 455(7216):1061-1068.
3. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O'Kelly M, Tamayo P, Weir BA, Gabriel S, Winckler W, Gupta S, Jakkula L, Feiler HS, Hodgson JG, James CD, Sarkaria JN, Brennan C, Kahn A, Spellman PT, Wilson RK, Speed TP, Gray JW, Meyerson M, Getz G, Perou CM, Hayes DN: Cancer Genome Atlas Research Network. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010, 17(1):98-110.
4. Pugh TJ, Morozova O, Attiyeh EF, Asgharzadeh S, Wei JS, Auclair D, Carter SL, Cibulskis K, Hanna M, Kiezun A, Kim J, Lawrence MS, Lichenstein L, McKenna A, Pedamallu CS, Ramos AH, Shefler E, Sivachenko A, Sougnez C, Stewart C, Ally A, Birol I, Chiu R, Corbett RD, Hirst M, Jackman SD, Kamoh B, Khodabakshi AH, Krzywinski M, Lo A, et al: The genetic landscape of high-risk neuroblastoma. Nat Genet 2013, 45(3):279-284.
5. Nik-Zainal S, Van Loo P, Wedge DC, Alexandrov LB, Greenman CD, Raine K, Breast Cancer Working Group of the International Cancer Genome Consortium, Lau KW, Raine K, Jones D, Marshall J, Ramakrishna M, Shlien A, Cooke SL, Hinton J, Menzies A, Stebbings LA, Leroy C, Jia M, Rance R, Mudie LJ, Gamble SJ, Stephens PJ, McLaren S, Tarpey PS, Papaemmanuil E, Davies HR, Varela I, McBride DJ, Bignell GR, et al: The life history of 21 breast cancers. Cell 2012, 149(5):994-1007.
6. Kazma R, Babron MC, Gaborieau V, Génin E, Brennan P, Hung RJ, ILCCO consortium, McLaughlin JR, Krokan HE, Elvestad MB, Skorpen F, Anderssen E, Vooder T, Välk K, Metspalu A, Field JK, Lathrop M, Sarasin A, Benhamou S, ILCCO consortium: Lung cancer and DNA repair genes: multilevel association analysis from the International Lung Cancer Consortium. Carcinogenesis 2012, 33(5):1059-1064.
7. Tan IB, Ng I, Tai WM, Tan P: Understanding the genetic basis of gastric cancer: recent advances. Expert Rev Gastroenterol Hepatol 2012, 6(3):335-341.
8. Zaal A, Peyrot WJ, Berns PM, van der Burg ME, Veerbeek JH, Trimbos JB, Cadron I, van Diest PJ, van Wieringen WN, Krijgsman O, Meijer GA, Piek JM, Timmers PJ, Vergote I, Verheijen RH, Ylstra B, Zweemer RP, EORTC GCG Translational Research Group: Genomic aberrations relate early and advanced stage ovarian cancer. Cell Oncol (Dordr) 2012, 35(3):181-188.
9. Teschendorff AE, Caldas C: The breast cancer somatic 'muta-ome': Tackling the complexity. Breast Cancer Res 2009, 11(2):301.
10. Hanahan D, Weinberg RA: Hallmarks of cancer: The next generation. Cell 2011, 144(5):646-674. 201.
11. Wood LD, Parsons DW, Jones S, Lin J, Sjöblom T, Leary RJ, Shen D, Boca SM, Barber T, Ptak J, Silliman N, Szabo S, Dezso Z, Ustyanksky V, Nikolskaya T, Nikolsky Y, Karchin R, Wilson PA, Kaminker JS, Zhang Z, Croshaw R, Willis J, Dawson D, Shipitsin M, Willson JK, Sukumar S, Polyak K, Park BH, Pethiyagoda CL, Pant PV, et al: The genomic landscapes of human breast and colorectal cancers. Science 2007, 318(5853):1108-1113. (Pubitemid 350134889)
12. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, Hong SM, Fu B, Lin MT, Calhoun ES, Kamiyama M, Walter K, Nikolskaya T, Nikolsky Y, Hartigan J, Smith DR, Hidalgo M, Leach SD, Klein AP, Jaffee EM, Goggins M, Maitra A, Iacobuzio-Donahue C, Eshleman JR, Kern SE, Hruban RH, et al: Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008, 321(5897):1801-1806.
13. Lazzara MJ, Lauffenburger DA: Quantitative modeling perspectives on the ErbB system of cell regulatory processes. Exp Cell Res 2009, 315:717-725.
14. Amir e-AD, Davis KL, Tadmor MD, Simonds EF, Levine JH, Bendall SC, Shenfeld DK, Krishnaswamy S, Nolan GP, Pe'er D: viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia. Nat Biotechnol 2013, 31(6):545-552.
15. García-Foncillas J, Bandrés E, Zárate R, Remírez N: Proteomic analysis in cancer research: potential application in clinical use. Clin Transl Oncol 2006, 8(4):250-261.
16. Whiteaker JR, Zhao L, Abbatiello SE, Burgess M, Kuhn E, Lin C, Pope ME, Razavi M, Anderson NL, Pearson TW, Carr SA, Paulovich AG: Evaluation of large scale quantitative proteomic assay development using peptide affinity-based mass spectrometry. Mol Cell Proteomics 2011, 10(4):M110.005645.
17. Pierobon M, Calvert V, Belluco C, Garaci E, Deng J, Lise M, Nitti D, Mammano E, Marchi FD, Liotta L, Petricoin E: Multiplexed cell signaling analysis of metastatic and nonmetastatic colorectal cancer reveals COX2-EGFR signaling activation as a potential prognostic pathway biomarker. Clin Colorectal Cancer 2009, 8(2):110-117.
18. Krishhan VV, Khan IH, Luciw PA: Multiplexed microbead immunoassays by flow cytometry for molecular profiling: basic concepts and proteomics applications. Crit Rev Biotechnol 2009, 29(1):29-43.
19. Kreeger PK, Lauffenburger DA: Cancer systems biology: A network modeling perspective. Carcinogenesis 2010, 31(1):2-8.
20. Schweppe DK, Rigas JR, Gerber SA: Quantitative phosphoproteomic profiling of human non-small cell lung cancer tumors. J Proteomics 2013, 91:286-296.
21. Atrih A, Mudaliar MA, Zakikhani P, Lamont DJ, Huang JT, Bray SE, Barton G, Fleming S, Nabi G: Quantitative proteomics in resected renal cancer tissue for biomarker discovery and profiling. Br J Cancer. 2014, doi:10.1038/bjc.2014. 24.
22. Zhang L, Zhou F, Drabsch Y, Gao R, Snaar-Jagalska BE, Mickanin C, Huang H, Sheppard KA, Porter JA, Lu CX, ten Dijke P: USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor. Nat Cell Biol 2012, 14(7):717-726.
23. Chapnick DA, Warner L, Bernet J, Rao T, Liu X: Partners in crime: The TGFβ and MAPK pathways in cancer progression. Cell Biosci 2011, 1:42.
24. Schiff R, Massarweh SA, Shou J, Bharwani L, Mohsin SK, Osborne CK: Cross-Talk between estrogen receptor and growth factor pathways as a molecular target for overcoming endocrine resistance. Clin Cancer Res 2004, 10(1 Pt 2):331S-336S. (Pubitemid 38116639)
25. Yang XJ, Seto E: Lysine acetylation: codified crosstalk with other posttranslational modifications. Mol Cell 2008, 31(4):449-461.
26. Beli P, Lukashchuk N, Wagner SA, Weinert BT, Olsen JV, Baskcomb L, Mann M, Jackson SP, Choudhary C: Proteomic investigations reveal a role for RNA processing factor THRAP3 in the DNA damage response. Mol Cell 2012, 46(2):212-225.
27. Oyama M, Nagashima T, Suzuki T, Kozuka-Hata H, Yumoto N, Shiraishi Y, Ikeda K, Kuroki Y, Gotoh N, Ishida T, Inoue S, Kitano H, Okada-Hatakeyama M: Integrated quantitative analysis of the phosphoproteome and transcriptome in tamoxifen-resistant breast cancer. J Biol Chem 2011, 286(1):818-829.
28. Xue L, Wang WH, Iliuk A, Hu L, Galan JA, Yu S, Hans M, Geahlen RL, Tao WA: Sensitive kinase assay linked with phosphoproteomics for identifying direct kinase substrates. Proc Natl Acad Sci U S A 2012, 109(15):5615-5620.
29. Hu S, Xie Z, Qian J, Blackshaw S, Zhu H: Functional protein microarray technology. Wiley Interdiscip Rev Syst Biol Med 2011, 3(3):255-268.
30. Choudhary C, Mann M: Decoding signalling networks by mass spectrometry-based proteomics. Nat Rev Mol Cell Biol 2010, 11(6):427-439.
31. Gembitsky DS, Lawlor K, Jacovina A, Yaneva M, Tempst P: A prototype antibody microarray platform to monitor changes in protein tyrosine phosphorylation. Mol Cell Proteomics 2004, 3(11):1102-1118. (Pubitemid 40012103)
32. Nomura DK, Dix MM, Cravatt BF: Activity-based protein profiling for biochemical pathway discovery in cancer. Nat Rev Cancer 2010, 10(9):630-638.
33. Jessani N, Niessen S, Wei BQ, Nicolau M, Humphrey M, Ji Y, Han W, Noh DY, Yates JR 3rd, Jeffrey SS, Cravatt BF: A streamlined platform for high-content functional proteomics of primary human specimens. Nat Methods 2005, 2(9):691-697. (Pubitemid 41223096)
34. Speers AE, Cravatt BF: Profiling enzyme activities in vivo using click chemistry methods. Chem Biol 2004, 11:535-546. (Pubitemid 38511759)
35. Cohen MS, Hadjivassiliou H, Taunton J: A clickable inhibitor reveals contextdependent autoactivation of p90 RSK. Nature Chem Biol 2007, 3:156-160.
36. Kumar S, Zhou B, Liang F, Wang WQ, Huang Z, Zhang ZY: Activity-based probes for protein tyrosine phosphatases. Proc Natl Acad Sci U S A 2004, 101:7943-7948. (Pubitemid 38698033)
37. Salisbury CM, Cravatt BF: Activity-based probes for proteomic profiling of histone deacetylase complexes. Proc Natl Acad Sci U S A 2007, 104(4):1171-1176. (Pubitemid 46183977)
38. Rolén U, Kobzeva V, Gasparjan N, Ovaa H, Winberg G, Kisseljov F, Masucci MG: Activity profiling of deubiquitinating enzymes in cervical carcinoma biopsies and cell lines. Mol Carcinog 2006, 45(4):260-269.
39. Patricelli MP, Szardenings AK, Liyanage M, Nomanbhoy TK, Wu M, Weissig H, Aban A, Chun D, Tanner S, Kozarich JW: Functional interrogation of the kinome using nucleotide acyl phosphates. Biochemistry 2007, 46(2):350-358. (Pubitemid 46105428)
40. Stains CI, Luković E, Imperiali B: A p38α-selective chemosensor for use in unfractionated cell lysates. ACS Chem Biol 2011, 6(1):101-105.
41. Stains CI, Tedford NC, Walkup TC, Luković E, Goguen BN, Griffith LG, Lauffenburger DA, Imperiali B: Interrogating signaling nodes involved in cellular transformations using kinase activity probes. Chem Biol 2012, 19(2):210-217.
42. Guruharsha KG, Rual JF, Zhai B, Mintseris J, Vaidya P, Vaidya N, Beekman C, Wong C, Rhee DY, Cenaj O, McKillip E, Shah S, Stapleton M, Wan KH, Yu C, Parsa B, Carlson JW, Chen X, Kapadia B, VijayRaghavan K, Gygi SP, Celniker SE, Obar RA, Artavanis-Tsakonas S: A protein complex network of Drosophila melanogaster. Cell 2011, 147:690-703.
43. Krogan NJ, Cagney G, Yu H, Zhong G, Guo X, Ignatchenko A, Li J, Pu S, Datta N, Tikuisis AP, Punna T, Peregrín-Alvarez JM, Shales M, Zhang X, Davey M, Robinson MD, Paccanaro A, Bray JE, Sheung A, Beattie B, Richards DP, Canadien V, Lalev A, Mena F, Wong P, Starostine A, Canete MM, Vlasblom J, Wu S, Orsi C, et al: Global landscape of protein complexes in the yeast Saccharomyces cerevisiae. Nature 2006, 440:637-643.
44. Völkel P, Le Faou P, Angrand PO: Interaction proteomics: characterization of protein complexes using tandem affinity purification-mass spectrometry. Biochem Soc Trans 2010, 38(4):883-887.
45. Angrand PO, Segura I, Völkel P, Ghidelli S, Terry R, Brajenovic M, Vintersten K, Klein R, Superti-Furga G, Drewes G, Kuster B, Bouwmeester T, Acker-Palmer A: Transgenic mouse proteomics identifies new 14-3-3 associated proteins involved in cytoskeletal rearrangements and cell signaling. Mol Cell Proteomics 2006, 5:2211-2227. (Pubitemid 46040629)
46. Bandyopadhyay S, Chiang CY, Srivastava J, Gersten M, White S, Bell R, Kurschner C, Martin C, Smoot M, Sahasrabudhe S, Barber DL, Chanda SK, Ideker T: A human MAP kinase interactome. Nat Methods 2010, 7(10):801-805.
47. Vinayagam A, Stelzl U, Foulle R, Plassmann S, Zenkner M, Timm J, Assmus HE, Andrade-Navarro MA, Wanker EE: A directed protein interaction network for investigating intracellular signal transduction. Sci Signal 2011, 4:rs8.
48. Scott JD, Pawson T: Cell signaling in space and time: where proteins come together and when They're apart. Science 2009, 326(5957):1220-1224.
49. Fillatre J, Delacour D, Van Hove L, Bagarre T, Houssin N, Soulika M, Veitia RA, Moreau J: Dynamics of the subcellular localization of RalBP1/RLIP through the cell cycle: The role of targeting signals and of protein-protein interactions. FASEB J 2012, 26(5):2164-2174.
50. Kolch W, Pitt A: Functional proteomics to dissect tyrosine kinase signalling pathways in cancer. Nat Rev Cancer 2010, 10:618-629.
51. Blagoev B, Kratchmarova I, Ong SE, Nielsen M, Foster LJ, Mann M: A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. Nat Biotechnol 2003, 21:315-318. (Pubitemid 36314817)
52. Wepf A, Glatter T, Schmidt A, Aebersold R, Gstaiger M: Quantitative interaction proteomics using mass spectrometry. Nat Methods 2009, 6:203-205.
53. Keshishian H, Addona T, Burgess M, Mani DR, Shi X, Kuhn E, Sabatine MS, Gerszten RE, Carr SA: Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution. Mol Cell Proteomics 2009, 8(10):2339-2349.
54. Ciccimaro E, Hanks SK, Yu KH, Blair IA: Absolute quantification of phosphorylation on the kinase activation loop of cellular focal adhesion kinase by stable isotope dilution liquid chromatography/mass spectrometry. Anal Chem 2009, 81(9):3304-3313.
55. Boja ES, Rodriguez H: Mass spectrometry-based targeted quantitative proteomics: Achieving sensitive and reproducible detection of proteins. Proteomics 2012, 12(8):1093-1110.
56. Janes KA, Albeck JG, Peng LX, Sorger PK, Lauffenburger DA, Yaffe MB: A high-Throughput quantitative multiplex kinase assay for monitoring information flow in signaling networks: Application to sepsis-Apoptosis. Mol Cell Proteomics 2003, 2:463-473.
57. Versteeg HH, Nijhuis E, van den Brink GR, Evertzen M, Pynaert GN, van Deventer SJ, Coffer PJ, Peppelenbosch MP: A new phosphospecific cell-based ELISA for p42/p44 mitogen-Activated protein kinase (MAPK), p38 MAPK, protein kinase B and cAMP-response-element-binding protein. Biochem J 2000, 350(Pt 3):717-722.
58. Malinowsky K, Wolff C, Ergin B, Berg D, Becker KF: Deciphering signaling pathways in clinical tissues for personalized medicine using protein microarrays. J Cell Physiol 2010, 225:364-370.
59. Paweletz CP, Charboneau L, Bichsel VE, Simone NL, Chen T, Gillespie JW, Emmert-Buck MR, Roth MJ, Petricoin EF III, Liotta LA: Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 2001, 20(16):1981-1989. (Pubitemid 32458030)
60. Einspahr JG, Calvert V, Alberts DS, Curiel-Lewandrowski C, Warneke J, Krouse R, Stratton SP, Liotta L, Longo C, Pellacani G, Prasad A, Sagerman P, Bermudez Y, Deng J, Bowden GT, Petricoin EF 3rd: Functional protein pathway activation mapping of the progression of normal skin to squamous cell carcinoma. Cancer Prev Res (Phila) 2012, 5(3):403-413.
61. Von Kriegsheim A, Baiocchi D, Birtwistle M, Sumpton D, Bienvenut W, Morrice N, Yamada K, Lamond A, Kalna G, Orton R, Gilbert D, Kolch W: Cell fate decisions are specified by the dynamic ERK interactome. Nat Cell Biol 2009, 11:1458-1464.
62. Matallanas D, Romano D, Yee K, Meissl K, Kucerova L, Piazzolla D, Baccarini M, Vass JK, Kolch W, O'neill E: RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein. Mol Cell 2007, 27:962-975. (Pubitemid 47495894)
63. Janes KA, Yaffe MB: Data-driven modelling of signal-Transduction networks. Nat Rev Mol Cell Biol 2006, 7:820-828. (Pubitemid 44627475)
64. Zhang Y, Wolf-Yadlin A, Ross PL, Pappin DJ, Rush J, Lauffenburger DA, White FM: Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules. Mol Cell Proteomics 2005, 4:1240-1250. (Pubitemid 41448712)
65. Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M: Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006, 127(3):635-648. (Pubitemid 44647421)
66. Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER 3rd, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini N, Lerenthal Y, Shiloh Y, Gygi SP, Elledge SJ: ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007, 316:1160-1166. (Pubitemid 46877472)
67. Lowery DM, Clauser KR, Hjerrild M, Lim D, Alexander J, Kishi K, Ong SE, Gammeltoft S, Carr SA, Yaffe MB: Proteomic screen defines the polo-box domain interactome and identifies Rock2 as a Plk1 substrate. EMBO J 2007, 26:2262-2273. (Pubitemid 46685865)
68. Dubois F, Vandermoere F, Gernez A, Murphy J, Toth R, Chen S, Geraghty KM, Morrice NA, MacKintosh C: Differential 14-3-3 affinity capture reveals new downstream targets of phosphatidylinositol 3-kinase signaling. Mol Cell Proteomics 2009, 8:2487-2499.
69. Blethrow JD, Glavy JS, Morgan DO, Shokat KM: Covalent capture of kinase-specific phosphopeptides reveals Cdk1-cyclin B substrates. Proc Natl Acad Sci U S A 2008, 105:1442-1447. (Pubitemid 351346533)
70. Amanchy R, Zhong J, Molina H, Chaerkady R, Iwahori A, Kalume DE, Grønborg M, Joore J, Cope L, Pandey A: Identification of c-Src tyrosine kinase substrates using mass spectrometry and peptide microarrays. J Proteome Res 2008, 7(9):3900-3910.
71. Hood L, Rowen L: The human genome project: big science transforms biology and medicine. Genome Med 2013, 5(9):79.
72. Fischer HP: Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery. Biotechnol Annu Rev 2005, 11:1-68.
73. Zhang W, Wan YW, Allen GI, Pang K, Anderson ML, Liu Z: Molecular pathway identification using biological network-regularized logistic models. BMC Genomics 2013, 14(Suppl 8):S7.
74. Ciriello G, Cerami E, Sander C, Schultz N: Mutual exclusivity analysis identifies oncogenic network modules. Genome Res 2012, 22(2):398-406.
75. Cancer Genome Atlas Research Network: Integrated genomic analyses of ovarian carcinoma. Nature 2011, 474(7353):609-615.
76. Ben-Hamo R, Efroni S: Biomarker robustness reveals the PDGF network as driving disease outcome in ovarian cancer patients in multiple studies. BMC Syst Biol 2012, 6:3.
77. Cancer Genome Atlas Research Network, Weinstein, Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA, Ellrott K, Shmulevich I, Sander C, Stuart JM: The cancer genome atlas Pan-cancer analysis project. Nat Genet 2013, 45(10):1113-1120.
78. Wang Q, Chaerkady R, Wu J, Hwang HJ, Papadopoulos N, Kopelovich L, Maitra A, Matthaei H, Eshleman JR, Hruban RH, Kinzler KW, Pandey A, Vogelstein B: Mutant proteins as cancer-specific biomarkers. Proc Natl Acad Sci U S A 2011, 108(6):2444-2449.
79. Rosenbloom KR, Dreszer TR, Long JC, Malladi VS, Sloan CA, Raney BJ, Cline MS, Karolchik D, Barber GP, Clawson H, Diekhans M, Fujita PA, Goldman M, Gravell RC, Harte RA, Hinrichs AS, Kirkup VM, Kuhn RM, Learned K, Maddren M, Meyer LR, Pohl A, Rhead B, Wong MC, Zweig AS, Haussler D, Kent WJ: ENCODE whole-genome data in the UCSC Genome Browser: update 2012. Nucleic Acids Res 2012, 40(Database issue):D912-D917.
80. Paik YK, Hancock WS: Uniting ENCODE with genome-wide proteomics. Nat Biotechnol 2012, 30(11):1065-1067.
81. Waters KM, Liu T, Quesenberry RD, Willse AR, Bandyopadhyay S, Kathmann LE, Weber TJ, Smith RD, Wiley HS, Thrall BD: Network analysis of epidermal growth factor signaling using integrated genomic, proteomic and phosphorylation data. PLoS One 2012, 7(3):e34515.
82. Torkamani A, Schork NJ: Identification of rare cancer driver mutations by network reconstruction. Genome Res 2009, 19(9):1570-1578.
83. Chen R, Mias GI, Li-Pook-Than J, Jiang L, Lam HY, Chen R, Miriami E, Karczewski KJ, Hariharan M, Dewey FE, Cheng Y, Clark MJ, Im H, Habegger L, Balasubramanian S, O'Huallachain M, Dudley JT, Hillenmeyer S, Haraksingh R, Sharon D, Euskirchen G, Lacroute P, Bettinger K, Boyle AP, Kasowski M, Grubert F, Seki S, Garcia M, Whirl-Carrillo M, Gallardo M, et al: Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell 2012, 148(6):1293-1307.
84. Jaffe JD, Berg HC, Church GM: Proteogenomic mapping as a complementary method to perform genome annotation. Proteomics 2004, 4(1):59-77. (Pubitemid 38140875)
85. Wang X, Slebos RJ, Wang D, Halvey PJ, Tabb DL, Liebler DC, Zhang B: Protein identification using customized protein sequence databases derived from RNA-Seq data. J Proteome Res 2012, 11(2):1009-1017.
86. Geiger T, Cox J, Mann M: Proteomic changes resulting from gene copy number variations in cancer cells. PLoS Genet 2010, 6(9):e1001090.
87. Armengaud J: Proteogenomics and systems biology: quest for the ultimate missing parts. Expert Rev Proteomics 2010, 7(1):65-77.
88. Findlay GD, MacCoss MJ, Swanson WJ: Proteomic discovery of previously unannotated, rapidly evolving seminal fluid genes in Drosophila. Genome Res 2009, 19(5):886-896.
89. Payne S, Huang ST, Pieper R: A proteogenomic update to Yersinia: enhancing genome annotation. BMC Genomics 2010, 11:460.
90. Prasad TS, Harsha HC, Keerthikumar S, Sekhar NR, Selvan LD, Kumar P, Pinto SM, Muthusamy B, Subbannayya Y, Renuse S, Chaerkady R, Mathur PP, Ravikumar R, Pandey A: Proteogenomic analysis of Candida glabrata using high resolution mass spectrometry. J Proteome Res 2012, 11(1):247-260.
91. Maier CW, Long JG, Hemminger BM, Giddings MC: Ultra-Structure database design methodology for managing systems biology data and analyses. BMC Bioinforma 2009, 10:254.
92. Jefferys SR, Giddings MC: Automated data integration and determination of posttranslational modifications with the protein inference engine. Methods Mol Biol 2011, 694:255-290.
93. Chen H, Yu T, Chen JY: Semantic Web meets integrative biology: A survey. Brief Bioinform 2013, 14(1):109-125.
94. Chen H, Ding L, Wu Z, Yu T, Dhanapalan L, Chen JY: Semantic web for integrated network analysis in biomedicine. Brief Bioinform 2009, 10(2):177-192.
95. Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, Muller J, Doerks T, Julien P, Roth A, Simonovic M, Bork P, von Mering C: STRING 8-A global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res 2009, 37(Database issue):D412-D416.
96. Turner B, Razick S, Turinsky AL, Vlasblom J, Crowdy EK, Cho E, Morrison K, Donaldson IM, Wodak SJ: iRefWeb: interactive analysis of consolidated protein interaction data and their supporting evidence. Database (Oxford) 2010, 2010:baq023.
97. Stark C, Breitkreutz BJ, Reguly T, Boucher L, Breitkreutz A, Tyers M: BioGRID: A general repository for interaction datasets. Nucleic Acids Res 2006, 34(Database issue):D535-D539.
98. Bader GD, Donaldson I, Wolting C, Ouellette BF, Pawson T, Hogue CW: BIND-The Biomolecular Interaction Network Database. Nucleic Acids Res 2001, 29:242-245. (Pubitemid 32054459)
99. Chatr-Aryamontri A, Ceol A, Palazzi LM, Nardelli G, Schneider MV, Castagnoli L, Cesareni G: MINT: The Molecular INTeraction database. Nucleic Acids Res 2007, 35(Database issue):D572-D574. (Pubitemid 46056272)
100. Xenarios I, Rice DW, Salwinski L, Baron MK, Marcotte EM, Eisenberg D: DIP: The database of interacting proteins. Nucleic Acids Res 2000, 28:289-291. (Pubitemid 30047782)
101. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M: KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res 2012, 40(Database issue):D109-D114.
102. Cerami EG, Gross BE, Demir E, Rodchenkov I, Babur O, Anwar N, et al: Pathway commons, a Web resource for biological pathway data. Nucleic Acids Res 2011, 39(Database issue):D685-D690.
103. Croft D, O'Kelly G, Wu G, Haw R, Gillespie M, Matthews L, Caudy M, Garapati P, Gopinath G, Jassal B, Jupe S, Kalatskaya I, Mahajan S, May B, Ndegwa N, Schmidt E, Shamovsky V, Yung C, Birney E, Hermjakob H, D'Eustachio P, Stein L: Reactome: A database of reactions, pathways and biological processes. Nucleic Acids Res 2011, 39(Database issue):D691-D697.
104. Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T: Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 2011, 27(3):431-432.
105. Hu Z, Hung JH, Wang Y, Chang YC, Huang CL, Huyck M, DeLisi C: VisANT 3.5: multi-scale network visualization, analysis and inference based on the gene ontology. Nucleic Acids Res 2009, 37(Web Server issue): W115-W121.
106. Shi Z, Wang J, Zhang B: NetGestalt: integrating multidimensional omics data over biological networks. Nat Methods 2013, 10(7):597-598.
107. Janes KA, Gaudet S, Albeck JG, Nielsen UB, Lauffenburger DA, Sorger PK: The response of human epithelial cells to TNF involves an inducible autocrine cascade. Cell 2006, 124(6):1225-1239.
108. Naegle M, Gymrek M, Joughin BA, Wagner JP, Welsch RE, Yaffe MB, Lauffenburger DA, White FM: PTMScout, a Web resource for analysis of high throughput post-Translational proteomics studies. Mol Cell Proteomics 2010, 9:2558-2570.
109. Naegle KM, Welsch RE, Yaffe MB, White FM, Lauffenburger DA: MCAM: multiple clustering analysis methodology for deriving hypotheses and insights from high-Throughput proteomic datasets. PLoS Comput Biol 2011, 7:e1002119.
110. Pe'er D: Bayesian network analysis of signaling networks: A primer. Sci STKE 2005, 2005(281):pl4.
111. Saez-Rodriguez J, Alexopoulos LG, Epperlein J, Samaga R, Lauffenburger DA, Klamt S, et al: Discrete logic modelling as a means to link protein signalling networks with functional analysis of mammalian signal transduction. Mol Syst Biol 2009, 5:331.
112. Alexander RP, Kim PM, Emonet T, Gerstein MB: Understanding modularity in molecular networks requires dynamics. Sci Signal 2009, 2(81):e44.
113. Novak B, Tyson JJ: Numerical analysis of a comprehensive model of M-phase control in Xenopus oocyte extracts and intact embryos. J Cell Sci 1993, 106(Pt 4):1153-1168. (Pubitemid 24018401)
114. Thattai M, van Oudenaarden A: Intrinsic noise in gene regulatory networks. Proc Natl Acad Sci USA 2001, 98:8614-8619. (Pubitemid 32678076)
115. Kholodenko BN, Kiyatkin A, Bruggeman FJ, Sontag E, Westerhoff HV, Hoek JB: Untangling the wires: A strategy to trace functional interactions in signaling and gene networks. Proc Natl Acad Sci U S A 2002, 99:12841-12846.
116. Santos SD, Verveer PJ, Bastiaens PI: Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate. Nat Cell Biol 2007, 9:324-330. (Pubitemid 46344612)
117. Harada T, Chelala C, Crnogorac-Jurcevic T, Lemoine NR: Genome-wide analysis of pancreatic cancer using microarray-based techniques. Pancreatology 2009, 9(1-2):13-24.
118. Taylor RC, Shah A, Treatman C, Blevins M: SEBINI: software Environment for Biological Network Inference. Bioinformatics (Oxford, England) 2006, 22(21):2706-2708. (Pubitemid 44642617)
119. Chuang HY, Lee E, Liu YT, Lee D, Ideker T: Network-based classification of breast cancer metastasis. Mol Syst Biol 2007, 3:140.
120. Schoeberl B, Pace EA, Fitzgerald JB, Harms BD, Xu L, Nie L, Linggi B, Kalra A, Paragas V, Bukhalid R, Grantcharova V, Kohli N, West KA, Leszczyniecka M, Feldhaus MJ, Kudla AJ, Nielsen UB: Therapeutically targeting ErbB3: A key node in ligand-induced activation of the ErbB receptor-PI3K axis. Sci Signal 2009, 2(77):ra31.
121. Kumar N, Wolf-Yadlin A, White FM, Lauffenburger DA: Modeling HER2 effects on cell behavior from mass spectrometry phosphotyrosine data. PLoS Comput Biol 2007, 3(1):e4.
122. Huang PH, Mukasa A, Bonavia R, Flynn RA, Brewer ZE, Cavenee WK, Furnari FB, White FM: Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma. Proc Natl Acad Sci U S A 2007, 104(31):12867-12872. (Pubitemid 47255246)
123. Kholodenko B, Yaffe MB, Kolch W: Computational approaches for analyzing information flow in biological networks. Sci Signal 2012, 5(220):re1.
124. Dalle Pezze P, Sonntag AG, Thien A, Prentzell MT, Gödel M, Fischer S, Neumann-Haefelin E, Huber TB, Baumeister R, Shanley DP, Thedieck K: A dynamic network model of mTOR signaling reveals TSC-independent mTORC2 regulation. Sci Signal 2012, 5:ra25.
125. Picotti P, Aebersold R: Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat Methods 2012, 9(6):555-566.
126. Bandyopadhyay S, Chiang CY, Srivastava J, Gersten M, White S, Bell R, Kurschner C, Martin C, Smoot M, Sahasrabudhe S, Barber DL, Chanda SK, Ideker T: A human MAP kinase interactome. Nat Methods 2010, 7(10):801-805.
127. Bai Y, Tolles J, Cheng H, Siddiqui S, Gopinath A, Pectasides E, Camp RL, Rimm DL, Molinaro AM: Quantitative assessment shows loss of antigenic epitopes as a function of pre-Analytic variables. Lab Invest 2011, 91(8):1253-1261.
128. Johnson H, White FM: Toward quantitative phosphotyrosine profiling in vivo. Semin Cell Dev Biol 2012, 23(8):854-862.
129. Guo Y, Graber A, McBurney RN, Balasubramanian R: Sample size and statistical power considerations in high-dimensionality data settings: A comparative study of classification algorithms. BMC Bioinforma 2010, 11:447.
130. Skates SJ, Gillette MA, LaBaer J, Carr SA, Anderson L, Liebler DC, Ransohoff D, Rifai N, Kondratovich M, Težak Ž, Mansfield E, Oberg AL, Wright I, Barnes G, Gail M, Mesri M, Kinsinger CR, Rodriguez H, Boja ES: Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies. J Proteome Res 2013, 12(12):5383-5394.
131. Liotta LA, Petricoin EF: 3rd.: - omics and cancer biomarkers: link to the biological truth or bear the consequences. Cancer Epidemiol Biomarkers Prev 2012, 21(8):1229-1235.
132. Wang E (Ed): Cancer Systems Biology. Chapman & Hall/CRC Mathematical and Computational Biology Series; 2010.
133. Boja E, Rivers R, Kinsinger C, Mesri M, Hiltke T, Rahbar A, Rodriguez H: Restructuring proteomics through verification. Biomark Med 2010, 4(6):799-803.
134. Berman H, Henrick K, Nakamura H: Announcing the worldwide protein data bank. Nat Struct Biol 2003, 10(12):980. (Pubitemid 37500485)
135. Gloriam DE, Orchard S, Bertinetti D, Björling E, Bongcam-Rudloff E, Borrebaeck CA, Bourbeillon J, Bradbury AR, de Daruvar A, Dübel S, Frank R, Gibson TJ, Gold L, Haslam N, Herberg FW, Hiltke T, Hoheisel JD, Kerrien S, Koegl M, Konthur Z, Korn B, Landegren U, Montecchi-Palazzi L, Palcy S, Rodriguez H, Schweinsberg S, Sievert V, Stoevesandt O, Taussig MJ, Ueffing M, et al: A community standard format for the representation of protein affinity reagents. Mol Cell Proteomics 2010, 9(1):1-10.
136. Deutsch EW: The PeptideAtlas project. Methods Mol Biol 2010, 604:285-296.
137. Farrah T, Deutsch EW, Kreisberg R, Sun Z, Campbell DS, Mendoza L, Kusebauch U, Brusniak MY, Hüttenhain R, Schiess R, Selevsek N, Aebersold R, Moritz RL: PASSEL: The PeptideAtlas SRMexperiment library. Proteomics 2012, 12(8):1170-1175.
138. Beasley-Green A, Bunk D, Rudnick P, Kilpatrick L, Phinney K: A proteomics performance standard to support measurement quality in proteomics. Proteomics 2012, 12(7):923-931.
139. MacLean B, Tomazela DM, Shulman N, Chambers M, Finney GL, Frewen B, Kern R, Tabb DL, Liebler DC, MacCoss MJ: Skyline: An open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 2010, 26(7):966-968.
140. Bereman MS, Johnson R, Bollinger J, Boss Y, Shulman N, Maclean B, Hoofnagle AN, Maccoss MJ: Implementation of statistical process control for proteomic experiments Via LC MS/MS. J Am Soc Mass Spectrom 2014, 25(4):581-587.
141. Bader GD, Cary MP, Sander C: Pathguide: A pathway resource list. Nucleic
142. Demir E, Cary MP, Paley S, Fukuda K, Lemer C, Vastrik I, Wu G, D'Eustachio P, Schaefer C, Luciano J, Schacherer F, Martinez-Flores I, Hu Z, Jimenez-Jacinto V, Joshi-Tope G, Kandasamy K, Lopez-Fuentes AC, Mi H, Pichler E, Rodchenkov I, Splendiani A, Tkachev S, Zucker J, Gopinath G, Rajasimha H, Ramakrishnan R, Shah I, Syed M, Anwar N, Babur O, et al: The BioPAX community standard for pathway data sharing. Nat Biotech 2010, 28:935-942.
143. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N: The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012, 2(5):401-404.
144. Hosseini P, Tremblay A, Matthews BF, Alkharouf NW: MAPT and PAICE: Tools for time series and single time point transcriptionist visualization and knowledge discovery. Bioinformation 2012, 8(6):287-289.
145. Wang L, Khankhanian P, Baranzini SE, Mousavi P: iCTNet: A Cytoscape plugin to produce and analyze integrative complex traits networks. BMC Bioinforma 2011, 12:380.
146. Madhavan S, Gusev Y, Harris M, Tanenbaum DM, Gauba R, Bhuvaneshwar K, Shinohara A, Rosso K, Carabet LA, Song L, Riggins RB, Dakshanamurthy S, Wang Y, Byers SW, Clarke R, Weiner LM: G-DOC: A systems medicine platform for personalized oncology. Neoplasia 2011, 13(9):771-783.
147. Junker BH, Klukas C, Schreiber F: VANTED: A system for advanced data analysis and visualization in the context of biological networks. BMC Bioinforma 2006, 7:109.
148. Gehlenborg N, O'Donoghue SI, Baliga NS, Goesmann A, Hibbs MA, Kitano H, Kohlbacher O, Neuweger H, Schneider R, Tenenbaum D, Gavin AC: Visualization of omics data for systems biology. Nat Methods 2010, 7(3 Suppl):S56-S68.